This blog is related to the various litigations related to patents w.r.t pharma industry.
Thursday, June 26, 2008
EMEA Recommends New Warnings and Contraindications for Ergot-derived Dopamine Agonists
June 26, 2008-The European Medicines Agency has recommended updating the product information for ergot-derived dopamine agonists with new warnings and contraindications in relation to the risk of fibrosis.
No comments:
Post a Comment